A Technological Catching-Up Model of Modularized Industry in Developing Countries

This article discussed the technological catching-up problem of modularized industry in developing countries. Firstly, this article analysed the relationship between technical level, technology learning capability, technological innovation capability and technological capability; then, stated that the technological catching-up of modularized industry in developing countries is the integration of catching-up in technical level and technological capability. After comparing the developing mode of modularized industries in developing countries with that in developed countries, this article puts forward a technological catching-up model of modularized industry in developing countries

Systematic Review and Meta-Analysis on the Association Between Outpatient Statins Use and Infectious Disease-Related Mortality

Background: To update and refine systematic literature review on the association between outpatient statins use and mortality in patients with infectious disease. Materials and Methods: We searched articles published before September 31, 2012, on the association between statins and infectious disease-related mortality through electronic databases. Eligible articles were analyzed in Review Manager 5.1. We conducted stratification analysis by study design, infection types, clinical outcomes and study locations. Results: The pooled odds ratio (OR) for death (statins use vs. no use) across the 41 included studies was 0.71 (95% confidence interval: 0.64, 0.78). The corresponding pooled ORs were 0.58 (0.38, 0.90), 0.66 (0.57, 0.75), 0.71 (0.57, 0.89) and 0.83 (0.67, 1.04) for the case-control study, retrospective cohort studies, prospective cohort studies and RCTs; 0.40 (0.20, 0.78), 0.61 (0.41, 0.90), 0.69 (0.62, 0.78) and 0.86 (0.68, 1.09) for bacteremia, sepsis, pneumonia and other infections; 0.62 (0.534, 0.72), 0.68 (0.53, 0.89), 0.71 (0.61, 0.83) and 0.86 (0.70, 1.07) for 30-day, 90-day, in-hospital and long-term (>1 year) mortality, respectively. Conclusions: Outpatient statins use is associated with a lower risk of death in patients with infectious disease in observational studies, but in a less extent in clinical trials. This association also varies considerably by infection types and clinical outcomes